USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR

• 收藏
• 分享

专利权人:

Bayer Pharma Aktiengesellschaft

发明人:

ELLINGHAUS, Peter,HEROULT, Melanie

申请号：

SG11201704090W

公开号：

SG11201704090WA

申请日:

2015.12.08

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The current invention is based on a pan FGFR inhibitor for use in the treatment of cancer in a subject, wherein the subject is one for whom the sum of FGFR1, FGFR2 and/ or FGFR3 mRNA in a tumor tissue sample from the subject has been found to be overexpressed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/